Hot Features
プレミアム
Cytokinetics Inc (CYTK)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Edward M. KayeIndependent Director | -2.93k | 223.17k | 売り | 76.09 | 10.28k | -22.19% |
| 2026-06-01 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -15.00k | 762.30k | Derivative Exercise and Sale | 23.26 - 74.08 | 1.59k | - |
| 2026-06-01 | Ms. B. Lynne ParshallIndependent Director | -5.00k | 370.40k | 売り | 74.08 | 15.78k | -24.06% |
| 2026-05-27 | Mr. Robert I. BlumCEO, President & Director | -7.50k | 579.08k | 売り | 77.21 | 239.78k | -3.03% |
| 2026-05-19 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -3.50k | 237.62k | Derivative Exercise and Sale | 7.80 - 75.69 | 98.66k | - |
| 2026-05-14 | Mr. Robert I. BlumCEO, President & Director | -7.50k | 584.40k | 売り | 77.92 | 247.28k | -2.94% |
| 2026-05-05 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -3.50k | 243.50k | Derivative Exercise and Sale | 7.80 - 77.37 | 98.66k | - |
| 2026-05-05 | Dr. Wendell D. WierengaIndependent Director | -4.03k | 252.40k | Derivative Exercise and Sale | 12.40 - 75.00 | 32.64k | - |
| 2026-05-05 | Mr. Sung H. LeeEVP & CFO | -23.91k | 1.84M | 売り | 76.87 | 2.15k | -91.74% |
| 2026-05-05 | Dr. John Tannahill HendersonIndependent Chairman | -20.00k | 1.37M | Derivative Exercise and Sale | 7.61 - 75.97 | 67.99k | - |
| 2026-05-05 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -11.33k | 432.01k | Derivative Exercise and Sale | 39.13 - 77.25 | 1.59k | - |
| 2026-05-01 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -15.86k | 434.01k | Derivative Exercise and Sale | 37.63 - 65.00 | 1.59k | - |
| 2026-04-30 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -15.00k | 600.00k | Derivative Exercise and Sale | 23.26 - 63.26 | 1.59k | - |
| 2026-04-29 | Mr. Robert I. BlumCEO, President & Director | -7.50k | 447.15k | 売り | 59.62 | 254.78k | -2.86% |
| 2026-04-21 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -3.50k | 202.62k | Derivative Exercise and Sale | 7.80 - 65.69 | 98.66k | - |
| 2026-04-15 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -7.45k | 491.78k | 売り | 66.02 | 1.59k | -82.42% |
| 2026-04-15 | Mr. Robert I. BlumCEO, President & Director | -7.50k | 490.35k | 売り | 65.38 | 262.28k | -2.78% |
| 2026-04-07 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -4.50k | 255.09k | Derivative Exercise and Sale | 7.80 - 65.21 | 98.66k | - |
| 2026-04-01 | Mr. Robert I. BlumCEO, President & Director | -7.50k | 499.73k | 売り | 66.63 | 269.78k | -2.70% |
| 2026-03-31 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -3.64k | 236.54k | 売り | 65.00 | 9.04k | -28.71% |
| 2026-03-17 | Mr. Sung H. LeeEVP & CFO | -4.94k | 306.71k | 売り | 62.15 | 87.13k | -5.36% |
| 2026-03-17 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -10.47k | 650.68k | 売り | 62.07 - 62.15 | 14.61k | -41.76% |
| 2026-03-17 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -12.03k | 747.85k | 売り | 62.15 | 98.66k | -10.87% |
| 2026-03-17 | Mr. Robert I. BlumCEO, President & Director | -36.60k | 2.27M | 売り | 62.15 | 277.28k | -11.66% |
| 2026-03-16 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -1.71k | 104.30k | 売り | 61.03 | 23.15k | -6.88% |
| 2026-03-09 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -2.58k | 156.78k | 売り | 60.72 | 5.01k | -34.03% |
| 2026-03-09 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.91k | 176.51k | 売り | 60.72 | 86.38k | -3.26% |
| 2026-03-09 | Mr. Robert I. BlumCEO, President & Director | -7.93k | 481.57k | 売り | 60.72 | 242.85k | -3.16% |
| 2026-03-02 | Ms. B. Lynne ParshallIndependent Director | -5.00k | 306.05k | 売り | 61.21 | 10.60k | -32.05% |
| 2026-03-02 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -886.00 | 21.26k | Derivative Exercise and Sale | 37.63 - 61.62 | 1.59k | - |
| 2026-02-05 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -15.00k | 580.05k | Derivative Exercise and Sale | 23.26 - 61.93 | 1.59k | - |
| 2026-02-02 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -886.00 | 21.68k | Derivative Exercise and Sale | 37.63 - 62.10 | 1.59k | - |
| 2026-01-05 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -15.00k | 555.30k | Derivative Exercise and Sale | 23.26 - 60.28 | 1.59k | - |
| 2026-01-02 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -913.00 | 56.69k | 売り | 62.09 | 1.59k | -36.51% |
| 2026-01-02 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -885.00 | 22.59k | Derivative Exercise and Sale | 37.63 - 63.16 | 1.59k | - |
| 2025-12-29 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -1.81k | 112.95k | 売り | 62.44 | 2.50k | -41.97% |
| 2025-12-22 | Mr. Robert I. BlumCEO, President & Director | -2.94k | 184.08k | Sale to Issuer | 62.72 | 234.28k | -1.24% |
| 2025-12-22 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -1.02k | 63.72k | Sale to Issuer | 62.72 | 81.29k | -1.23% |
| 2025-12-22 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -675.00 | 42.34k | Sale to Issuer | 62.72 | 4.31k | -13.54% |
| 2025-12-22 | Mr. Sung H. LeeEVP & CFO | -805.00 | 50.49k | Sale to Issuer | 62.72 | 17.92k | -4.30% |
| 2025-12-22 | Mr. Robert I. BlumCEO, President & Director | 40.81k | 272.18k | Derivative Exercise and Retained Stock | 6.67 | 225.69k | 22.07% |
| 2025-12-22 | Mr. Robert I. BlumCEO, President & Director | -30.43k | 1.87M | Derivative Exercise and Sale | 6.67 - 68.18 | 225.69k | - |
| 2025-12-22 | Dr. Wendell D. WierengaIndependent Director | -20.00k | 1.17M | Derivative Exercise and Sale | 7.61 - 66.14 | 32.44k | - |
| 2025-12-16 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.20k | 111.41k | Derivative Exercise and Sale | 10.60 - 61.24 | 78.30k | - |
| 2025-12-08 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -1.04k | 27.96k | Derivative Exercise and Sale | 39.13 - 65.96 | 1.81k | - |
| 2025-12-05 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -52.49k | 1.69M | Derivative Exercise and Sale | 23.26 - 65.95 | 1.81k | - |
| 2025-12-03 | Mr. Sung H. LeeEVP & CFO | -1.56k | 101.43k | Sale to Issuer | 65.02 | 14.42k | -9.76% |
| 2025-12-03 | Mr. Andrew M. CallosExec. VP & Chief Commercial Officer | -1.37k | 88.95k | Sale to Issuer | 65.02 | 1.81k | -43.07% |
| 2025-12-03 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.06k | 133.81k | Sale to Issuer | 65.02 | 78.30k | -2.56% |
| 2025-12-03 | Mr. Robert I. BlumCEO, President & Director | -5.93k | 385.57k | Sale to Issuer | 65.02 | 184.88k | -3.11% |
| 2025-12-02 | Dr. John Tannahill HendersonIndependent Chairman | -8.75k | 471.63k | Derivative Exercise and Sale | 10.00 - 63.90 | 67.33k | - |
| 2025-12-02 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.20k | 117.24k | Derivative Exercise and Sale | 10.60 - 63.89 | 76.36k | - |
| 2025-12-01 | Dr. Edward M. KayeIndependent Director | -28.06k | 1.49M | Derivative Exercise and Sale | 12.40 - 66.72 | 2.64k | - |
| 2025-12-01 | Dr. Robert A. HarringtonIndependent Director | -2.15k | 143.62k | 売り | 66.80 | 11.21k | -16.09% |
| 2025-11-19 | Ms. B. Lynne ParshallIndependent Director | -5.00k | 323.65k | 売り | 64.73 | 15.60k | -24.27% |
| 2025-11-18 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.20k | 122.87k | Derivative Exercise and Sale | 10.60 - 66.45 | 76.36k | - |
| 2025-11-11 | Dr. Edward M. KayeIndependent Director | -5.18k | 286.80k | Derivative Exercise and Sale | 9.66 - 65.08 | 2.64k | - |
| 2025-11-05 | Mr. Robert I. BlumCEO, President & Director | -2.00k | 0.00 | Other Disposition | - | 179.25k | -1.10% |
| 2025-11-04 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.30k | 112.34k | Derivative Exercise and Sale | 10.60 - 59.55 | 76.36k | - |
| 2025-10-30 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 314.30k | 売り | 62.86 | 181.25k | -2.68% |
| 2025-10-27 | Dr. Wendell D. WierengaIndependent Director | -4.38k | 212.98k | Derivative Exercise and Sale | 10.00 - 58.68 | 32.44k | - |
| 2025-10-21 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.11k | 100.24k | Derivative Exercise and Sale | 10.60 - 58.22 | 76.36k | - |
| 2025-10-07 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.00k | 99.92k | Derivative Exercise and Sale | 10.60 - 60.56 | 76.36k | - |
| 2025-10-06 | Dr. Edward M. KayeIndependent Director | -6.76k | 405.42k | 売り | 60.00 | 2.45k | -73.43% |
| 2025-10-01 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 275.25k | 売り | 55.05 | 191.25k | -2.55% |
| 2025-09-30 | Dr. Edward M. KayeIndependent Director | -6.70k | 368.76k | 売り | 55.08 | 9.20k | -42.11% |
| 2025-09-23 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.00k | 77.36k | Derivative Exercise and Sale | 10.60 - 49.28 | 76.36k | - |
| 2025-09-15 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 248.85k | 売り | 49.77 | 196.25k | -2.48% |
| 2025-09-09 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.00k | 81.38k | Derivative Exercise and Sale | 10.60 - 51.29 | 76.36k | - |
| 2025-09-02 | Dr. Edward M. KayeIndependent Director | -6.76k | 337.80k | 売り | 50.00 | 15.90k | -29.82% |
| 2025-09-02 | Dr. Robert A. HarringtonIndependent Director | -2.15k | 104.64k | 売り | 48.67 | 13.16k | -14.04% |
| 2025-09-02 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 243.80k | 売り | 48.76 | 201.25k | -2.42% |
| 2025-08-19 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.00k | 55.42k | Derivative Exercise and Sale | 10.60 - 38.31 | 76.36k | - |
| 2025-08-15 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 192.10k | 売り | 38.42 | 206.25k | -2.37% |
| 2025-08-05 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.00k | 51.48k | Derivative Exercise and Sale | 10.60 - 36.34 | 76.36k | - |
| 2025-07-29 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 182.25k | 売り | 36.45 | 211.25k | -2.31% |
| 2025-07-22 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.00k | 53.74k | Derivative Exercise and Sale | 10.60 - 37.47 | 76.36k | - |
| 2025-07-14 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 190.75k | 売り | 38.15 | 216.25k | -2.26% |
| 2025-07-08 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.00k | 46.32k | Derivative Exercise and Sale | 10.60 - 33.76 | 76.36k | - |
| 2025-07-01 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 167.75k | 売り | 33.55 | 221.25k | -2.21% |
| 2025-06-17 | Dr. Fady Ibraham MalikExec. VP of Research & Development | -2.00k | 44.62k | Derivative Exercise and Sale | 10.60 - 32.91 | 76.36k | - |
| 2025-06-16 | Mr. Robert I. BlumCEO, President & Director | -5.00k | 169.00k | 売り | 33.80 | 226.25k | -2.16% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
